More doses of Shingrix are on the way, GlaxoSmithKline says

GlaxoSmithKline, the maker of the shingles vaccine Shingrix that has been in short supply, told customers Jan. 10 that more shipments of the vaccine are on the way to U.S. pharmacies, according to WebMD.

Advertisement
Alia Paavola

While more doses are on the way, the company warned that demand may still outpace supply.

GlaxoSmithKline has ordering limits in place, so a single provider can’t order and maintain a large stock.  

This year the company said it  plans to ramp up the frequency and volume of doses shipped.

More articles on supply chain:
3 digital health moves the FDA made in 2018
Novartis, VC firms invest $64M in ‘digital therapeutics’ company
BTG Pharmaceuticals tracks snake-bite treatment with blockchain in partnership with OMNY

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.